New York State Common Retirement Fund’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

New York State Common Retirement Fund’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-265,729	Closed	-$235K	–	3255
2022 Q4	$235K	Sell	265,729 -150	-0.1%	-$199	﹤0.01%	2667
2022 Q3	$417K	Buy	265,879 +1,204	+0.5%	+$2.73K	﹤0.01%	2426
2022 Q2	$532K	Buy	264,675 +63,674	+32%	+$110K	﹤0.01%	2333
2022 Q1	$468K	Buy	201,001 +16,735	+9%	+$52.2K	﹤0.01%	2428
2021 Q4	$857K	Sell	184,266 -471	-0.3%	-$2.92K	﹤0.01%	2169
2021 Q3	$1.41M	Sell	184,737 -50,878	-22%	-$431K	﹤0.01%	1954
2021 Q2	$2.28M	Buy	235,615 +20,515	+10%	+$163K	﹤0.01%	1789
2021 Q1	$1.78M	Sell	215,100 -10,500	-5%	-$111K	﹤0.01%	1845
2020 Q4	$1.54M	Buy	225,600 +25,400	+13%	+$204K	﹤0.01%	1814
2020 Q3	$2.23M	Buy	200,200 +39,500	+25%	+$362K	﹤0.01%	1508
2020 Q2	$1.01M	Buy	160,700 +67,000	+72%	+$257K	﹤0.01%	1863
2020 Q1	$172K	Hold	93,700	–	–	﹤0.01%	2531
2019 Q4	$317K	Hold	93,700	–	–	﹤0.01%	2519
2019 Q3	$201K	Hold	93,700	–	–	﹤0.01%	2771
2019 Q2	$250K	Hold	93,700	–	–	﹤0.01%	2710
2019 Q1	$445K	Hold	93,700	–	–	﹤0.01%	2362
2018 Q4	$225K	Buy	93,700 +13,000	+16%	+$42.5K	﹤0.01%	2658
2018 Q3	$355K	Hold	80,700	–	–	﹤0.01%	2574
2018 Q2	$581K	Buy	+80,700	New	+$549K	﹤0.01%	2385
2017 Q2	–	Sell	-25,901	Closed	-$102K	–	3262
2017 Q1	$102K	Buy	25,901 +1	+0%	+$5	﹤0.01%	2964
2016 Q4	$127K	Hold	25,900	–	–	﹤0.01%	2920
2016 Q3	$200K	Hold	25,900	–	–	﹤0.01%	2766
2016 Q2	$145K	Hold	25,900	–	–	﹤0.01%	2871
2016 Q1	$139K	Hold	25,900	–	–	﹤0.01%	2830
2015 Q4	$226K	Hold	25,900	–	–	﹤0.01%	2697
2015 Q3	$217K	Buy	25,900 +7,606	+42%	+$121K	﹤0.01%	2744
2015 Q2	$322K	Buy	+18,294	New	+$235K	﹤0.01%	2724

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $1.36B AUM 249.29% 1-Year Est. Return

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

OFA

Oaktree Fund Advisors Los Angles, California $57.8M AUM 67.22% 1-Year Est. Return

CGA

Crescent Grove Advisors Lake Forest, Illinois $1.2B AUM 23.08% 1-Year Est. Return

LCM

Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return

STB

S&T Bank Indiana, Pennsylvania $333M AUM 106.39% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

HFRG

Houlihan Financial Resource Group Ashburn, Virginia $281M AUM 17.68% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

GBWM

Granite Bay Wealth Management Portsmouth, New Hampshire $1.09B AUM 22.93% 1-Year Est. Return

New York State Common Retirement Fund's SRNE Position: Q1 2023 in Review

New York State Common Retirement Fund sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2023, closing a stake of 265,729 shares — an estimated $235K sold.

New York State Common Retirement Fund first reported a position in SRNE in Q2 2015 and held it in 27 quarters. The position peaked at $2.28M in Q2 2021. 34 funds tracked by Wall St. Rank hold SRNE as of Q1 2023.

New York State Common Retirement Fund reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2023 after selling out during the quarter.
New York State Common Retirement Fund sold 265,729 Sorrento Therapeutics, Inc. shares in Q1 2023, an estimated $235K.
New York State Common Retirement Fund first reported a position in Sorrento Therapeutics, Inc. in Q2 2015 and held it in 27 quarters.
New York State Common Retirement Fund's Sorrento Therapeutics, Inc. position peaked at $2.28M in Q2 2021.
34 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2023.

Based on New York State Common Retirement Fund's 13F filing for Q1 2023, filed 2 May 2023.